People · Operator
Named in public records as an officer, director or promoter · active 2008–2015 · Pharma, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| C2 Therapeutics Inc | — | Pharma | Series A | $25.9M | $195.1M | 2009 |
| Precision Light, Inc. | — | Other Health Care | Seed | $3.5M | $86.7M | 2008 |
FRANK T. WATKINS at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside FRANK T. WATKINS on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David H. Mordaunt | 1 | 2 |
| Tom H. Liolios | 1 | 2 |
| GREG T. GARFIELD | 1 | 1 |
| AARON T. BEREZ | 1 | 1 |
| Joe T. Mandato | 1 | 1 |
| PETER GARCIA-MEZA | 1 | 1 |
| G. Patrick Maxwell | 1 | 1 |
| RICK WILLIAMS | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.